Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, healt...

Full description

Bibliographic Details
Main Authors: Christian Thomas, Georg Bartsch, Christian Walter, Hendrik Borgmann, Maximilian Peter Brandt, Thomas Höfner, Axel Haferkamp, Igor Tsaur
Format: Article
Language:English
Published: MDPI AG 2016-08-01
Series:Dentistry Journal
Subjects:
Online Access:http://www.mdpi.com/2304-6767/4/3/28